Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM) Financial History

Name: Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Indore, India with about 24 employees. Its market capitalization is roughly ₹534 million. In the fiscal year ended 2026-03-31, BIOFILCHEM reported ₹284M in revenue and ₹28M in net income.

Biofil Chemicals and Pharmaceuticals Limited engages in the manufacturing and trading of pharmaceutical products in India. It operates through Pharma and Chemical segments.

Interactive charts & full statements →

BIOFILCHEM Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹284M	₹334M	₹400M	₹300M
Gross Profit	₹24M	₹26M	₹25M	₹26M
Operating Income (EBIT)	₹4M	₹5M	₹4M	₹7M
Net Income	₹28M	₹6M	₹7M	₹6M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BIOFILCHEM Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹124M	₹76M	₹9M	₹135M	₹64M	—	—
Gross Profit	₹5M	₹9M	₹4M	₹4M	₹4M	—	—
Operating Income (EBIT)	₹1M	₹4M	₹0M	₹0M	(₹1M)	—	—
Net Income	₹1M	₹2M	₹1M	₹1M	₹24M	—	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BIOFILCHEM Free Cash Flow History

BIOFILCHEM Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹428M	₹510M	₹471M	₹314M	—
Total Liabilities	₹213M	₹322M	₹289M	₹141M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BIOFILCHEM viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

TLRY · Tilray Brands, Inc. — $619 million
3737 · Zhongzhi Pharmaceutical Holdings Limited — HK$607 million
EOLS · Evolus, Inc. — $600 million
MANGALAM · Mangalam Drugs & Organics Limited — ₹542 million
EVT · Evotec SE — €518 million
KMDA · Kamada Ltd. — $478 million
VIVIMEDLAB · Vivimed Labs Limited — ₹463 million
CGC · Canopy Growth Corporation — $463 million

← BIOCON All “B” companies BION →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.